This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Estrogen receptor 3D structures
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 13: | Line 13: | ||
**[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | **[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | ||
**[[6d0f]], [[6cbz]], [[6czn]] - hERα LBD (mutant) + GRIP peptide<br /> | **[[6d0f]], [[6cbz]], [[6czn]] - hERα LBD (mutant) + GRIP peptide<br /> | ||
| + | **[[7rnm]] - hERα LBD + GRIP peptide + pyrimidine derivative<br /> | ||
| + | **[[7rke]], [[7sfo]], [[7t2x]] - hERα LBD (mutant) + GRIP peptide + pyrimidine derivative<br /> | ||
**[[6cbz]], [[5wgq]], [[5wgd]] - hERα LBD (mutant) + GRIP peptide + EST<br /> | **[[6cbz]], [[5wgq]], [[5wgd]] - hERα LBD (mutant) + GRIP peptide + EST<br /> | ||
**[[6pit]] - hERα LBD (mutant) + stapled peptide + EST<br /> | **[[6pit]] - hERα LBD (mutant) + stapled peptide + EST<br /> | ||
**[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | **[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | ||
| - | **[[ | + | **[[7ujo]] - hERα LBD + anti-hormone<br /> |
**[[7uj7]] - hERα LBD (mutant) + anti-hormone<br /> | **[[7uj7]] - hERα LBD (mutant) + anti-hormone<br /> | ||
**[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | **[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | ||
**[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | **[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | ||
| - | **[[6iar]], [[6dfn]], [[6df6]], [[6zoq]], [[6zor]], [[6zos]], [[7msa]] - hERα LBD + antagonist<br /> | + | **[[6iar]], [[6dfn]], [[6df6]], [[6zoq]], [[6zor]], [[6zos]], [[7msa], [[7r62]], [[7qvj]], [[7qvl]], [[7te7]], [[8du8]], [[8duc]], [[8dud]] [[8dui]] - hERα LBD + antagonist<br /> |
| - | **[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]], [[6chz]], [[6chw]], [[6c42]], [[6b0f]], [[5w9d]], [[5ufx]], [[5ufw]] - hERα LBD (mutant) + antagonist<br /> | + | **[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]], [[6chz]], [[6chw]], [[6c42]], [[6b0f]], [[5w9d]], [[5ufx]], [[5ufw]], [[7n9o]], [[7rrx]], [[7rry]], [[7rrz]], [[7rs0]], [[7rs1]], [[7rs2]], [[7rs3]], [[7rs4]], [[7rs7]], [[7rs8]],[[7rs9]], [[7wnv]], [[8du6]], [[8du9]], [[8dub]], [[8dug]], [[8duh]], [[8dus]], [[8dv5]], [[8dv7]], [[8dv8]], [[8dvb]], [[7ndo]], [[7uj8]], [[8ev1]], [[8ev2]] - hERα LBD (mutant) + antagonist<br /> |
**[[6owc]] - hERα LBD (mutant) + pyridine derivative<br /> | **[[6owc]] - hERα LBD (mutant) + pyridine derivative<br /> | ||
**[[4q50]], [[5w9c]], [[6v87]] - hERα LBD (mutant) + tamoxifen derivative<br /> | **[[4q50]], [[5w9c]], [[6v87]] - hERα LBD (mutant) + tamoxifen derivative<br /> | ||
| Line 27: | Line 29: | ||
**[[6pet]] - hERα LBD + hydroxychromene<br /> | **[[6pet]] - hERα LBD + hydroxychromene<br /> | ||
**[[6pfm]] - hERα LBD (mutant) + hydroxychromene<br /> | **[[6pfm]] - hERα LBD (mutant) + hydroxychromene<br /> | ||
| - | **[[6psj]], [[6vgh]], [[ | + | **[[6psj]], [[6vgh]], [[7ujy]], [7ujw]], [[7ujc]], [[7ujm]], [[7kbs]] - hERα LBD (mutant) + osteoporosis drug<br /> |
**[[6wok]] - hERα LBD + breast cancer drug<br /> | **[[6wok]] - hERα LBD + breast cancer drug<br /> | ||
**[[6suo]] - hERα LBD + indole derivative<br /> | **[[6suo]] - hERα LBD + indole derivative<br /> | ||
**[[6sq0]] - hERα LBD (mutant) + indole derivative<br /> | **[[6sq0]] - hERα LBD (mutant) + indole derivative<br /> | ||
**[[6v8t]] - hERα LBD (mutant) + benzothiophene derivative<br /> | **[[6v8t]] - hERα LBD (mutant) + benzothiophene derivative<br /> | ||
| - | **[[6vjd]], [[ | + | **[[6vjd]], [[7ujf]], [[6vpf]], [[7ujy]], [[7ujw]] - hERα LBD + modulator<br /> |
**[[6vgh]] - hERα LBD (mutant) + modulator<br /> | **[[6vgh]] - hERα LBD (mutant) + modulator<br /> | ||
**[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | **[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | ||
| Line 38: | Line 40: | ||
**[[2ocf]] - hERα LBD (mutant) + fibronectin domain 10 + EST<br /> | **[[2ocf]] - hERα LBD (mutant) + fibronectin domain 10 + EST<br /> | ||
**[[2yja]] - hERα LBD + NCAO2 peptide<br /> | **[[2yja]] - hERα LBD + NCAO2 peptide<br /> | ||
| - | **[[2b23]] - hERα LBD (mutant) + NCAO2 peptide<br /> | + | **[[2b23]], [[8ev1]], [[8ev2]] - hERα LBD (mutant) + NCAO2 peptide<br /> |
**[[4n1y]] - ERα LBD – pacific oyster<br /> | **[[4n1y]] - ERα LBD – pacific oyster<br /> | ||
| Line 57: | Line 59: | ||
**[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + NCAO2 peptide + ligand<br /> | **[[1gwq]], [[2fai]], [[2g44]], [[2qzo]] - hERα LBD + NCAO2 peptide + ligand<br /> | ||
**[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + NCAO2 peptide + ligand<br /> | **[[3l03]], [[3hm1]], [[3hlv]], [[1zky]], [[2b1v]], [[2b1z]], [[2qa6]], [[2qab]], [[2qgw]], [[2qh6]], [[2qr9]], [[2qse]], [[2qxm]] - hERα LBD (mutant) + NCAO2 peptide + ligand<br /> | ||
| - | **[[2qa8]] - hERα LBD (mutant) + NCAO2 peptide + genistein<br /> | + | **[[2qa8]], [[7nfb]] - hERα LBD (mutant) + NCAO2 peptide + genistein<br /> |
**[[4pp6]], [[4ppp]], [[4pps]] - hERα LBD (mutant) + NCAO2 peptide + resveratrol derivative<br /> | **[[4pp6]], [[4ppp]], [[4pps]] - hERα LBD (mutant) + NCAO2 peptide + resveratrol derivative<br /> | ||
| Line 87: | Line 89: | ||
**[[1x7e]] - hERα LBD + NCAO3 peptide + ligand<br /> | **[[1x7e]] - hERα LBD + NCAO3 peptide + ligand<br /> | ||
| - | *Estrogen receptor α DNA binding domain | + | *Estrogen receptor α DNA binding domain 182-252 |
**[[1hcp]] – hERα DBD – NMR<br /> | **[[1hcp]] – hERα DBD – NMR<br /> | ||
| Line 94: | Line 96: | ||
**[[6sbo]] – hERα residues 124-381 + pyrrolydin derivative<br /> | **[[6sbo]] – hERα residues 124-381 + pyrrolydin derivative<br /> | ||
| - | *Estrogen receptor β ligand binding domain | + | *Estrogen receptor β ligand binding domain 261-500 |
**[[1qkm]] - hERβ LBD + genistein<br /> | **[[1qkm]] - hERβ LBD + genistein<br /> | ||
| Line 111: | Line 113: | ||
**[[1u9e]] - hERβ LBD + NCAO peptide<br /> | **[[1u9e]] - hERβ LBD + NCAO peptide<br /> | ||
**[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + NCAO peptide + ligand<br /> | **[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + NCAO peptide + ligand<br /> | ||
| - | **[[1x7j]] - hERβ LBD + NCAO peptide + genistein | + | **[[1x7j]] - hERβ LBD + NCAO peptide + genistein<br /> |
| + | **[[7xvy]], [[7xvz]], [[7xwp]], [[7xwq]], [[7xwr]] - hERβ LBD (mutant) + NCAO1 peptide + DPN derivative<br /> | ||
| + | **[[7nel]] - hERβ LBD (mutant) + NCAO2 peptide + estradiol<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
Updated on 23-February-2023 - For a general description of the protein see Estrogen receptor
